Context:

A promising season for Zach Eflin derailed when an elbow issue forced Tommy John surgery, ending his 2026 campaign after only a brief exposure in one start. This followed a prior lumbar back procedure, complicating a highly anticipated reunion with the Orioles on a short-term, $10 million deal tied to a larger option. The sequence underscored how recurring injuries can upend movement and readiness, even for a pitcher who felt exceptional health in spring training. With rehab as the immediate focus, the path forward centers on regaining mobility and strength, while questions about his long-term fit with Baltimore linger into 2027 and beyond.

Dive Deeper:

• Eflin’s back issue required a lumbar microdiscectomy in August, with an expected four-to-eight month recovery, complicating his market timing ahead of free agency.

• Baltimore signaled commitment by bringing him back on a one-year contract worth $10 million, including a $2 million buyout on a $25 million 2027 option, aided by new teammates Shane Baz and Chris Bassitt.

• Spring training brought optimism as he returned with improved mobility after addressing a bone spur and herniation, and he unexpectedly cracked Baltimore’s opening rotation.

• During a start against the Texas Rangers, he felt his elbow seize in the fourth inning, signaling the end of his season and leading to Tommy John surgery on April 8.

• Career context includes 68 wins in 189 starts and 12.9 WAR, highlighting the high upside of his profile despite the setback and tight contract timing.

• Looking ahead, Eflin emphasizes intense rehab and readiness for a potential midseason return in 2027, while the Orioles weigh option decisions and how to align the roster around his long-term attendance.